NationalStockNumber.INFO
Worldwide distributor of NSN parts and consumables located in the USA.
Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Dermatological agents and local anesthetics put up in measured doses or in forms or packings for retail sale, nesoi
Medicaments, n.E.S., in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICU - Precious metal content is unknown
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Questions & Answers: |
|
| What are the historical prices recorded for this stock number? | |
| No pre-dated pricing for this NSN could be found. | |
| Does NSN 6505-00-063-6225 have a shelf life? | |
| No. There is no shelf life applicable for this NSN. | |
| What NATO entities are users of this NSN? | |
| Health Services Administration, and Veterans Administration | |
| What is the NIIN of NSN 6505-00-063-6225? | |
| 000636225 or 00-063-6225 | |
| Does NSN 6505-00-063-6225 require demilitarization? | |
| Yes - ITAR Controlled | |
| What is the most recent solicitation for NSN 6505-00-063-6225? | |
| No solicitations for this NSN. | |
| When was this national stock number assigned to the federal catalog? | |
| Jan 01, 1963 | |
Routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: ingestion: toxic effects on cns &
cardiovascular system. Skin: allergic reactions. Inhalation: mucous
membrane irritation, numbness, loss of sensation, nervousness,
confusion, drowsiness, vomiting, tr emors, convulsions, respiratory
depression, slowing of heart/blood pressure drop & unconsciousness.
eye: blurred vision.
explanation of carcinogenicity: none
effects of overexposure: ingestion: toxic effects on cns &
cardiovascular system. Skin: allergic reactions. Inhalation: mucous
membrane irritation, numbness, loss of sensation, nervousness,
confusion, drowsiness, vomiting, tr emors, convulsions, respiratory
depression, slowing of heart/blood pressure drop & unconsciousness.
eye: blurred vision.
medical cond aggravated by exposure: hypersensitivity, allergic
reactions. Loss of sensation
First aid: eyes: wash thoroughly with clean water for 15 minutes. Call
physician. Inhalation: medical attention should include maintenance
of breathing & controlling convulsions if they occur.
Boiling pt: b.P. Text: 100c
melt/freeze pt: m.P/f.P text: 0
vapor pres: 17
vapor density: 0.6
spec gravity: 1.02
evaporation rate & reference: (water = 1): 1
solubility in water: soluble
appearance and odor: slightly opaque viscous liquid slightly yellow
w/cherry odor
Stability indicator/materials to avoid: yes
compounds or materials which react violently w/water.
stability condition to avoid: extreme temperatures
hazardous decomposition products: none
Waste disposal methods: dispose as a non-hazardous waste under rcra, &
in accordance w/applicable regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: lidocaine hydrochloride
cas: 73-78-9
rtecs #: an7600000
fraction by wt: 2.0%